NEW YORK, Dec. 13 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb
Company (NYSE: BMY) will host a conference call on December 18 at 8:00 am
(ET) to review data presented at the American Society of Hematology (ASH)
48th Annual Meeting and Exposition, held from December 9-12 in Atlanta, FL.
Company executives will provide an overview of data presented at the
meeting for several oncology and cardiovascular compounds and address
questions from investors and analysts.
Investors and the general public are invited to listen to a live
webcast of the call at http://www.bms.com/ir or by dialing 913-981-5543. A
replay of the call will be available beginning at 2:00 p.m. (ET) on
December 18 through 8:00 p.m. (ET) on December 31. The replay can be
accessed at http://www.bms.com/ir or by dialing 402-280-9013 (access code
9358124).
Bristol-Myers Squibb is a global pharmaceutical and related health care
products company whose mission is to extend and enhance human life.
SOURCE Bristol-Myers Squibb Company
 back to top
Related links:
http://www.bms.com
http://www.bms.com/ir
CONTACT:
Media: Tony Plohoros, Communications,
+1-212-546-4379, tony.plohoros@bms.com, or Jeff Macdonald,
Communications, +1-212-546-4824, jeffrey.macdonald@bms.com, or
Investors: John Elicker, Investor Relations, +1-212-546-3775,
john.elicker@bms.com, or Blaine Davis, Investor Relations,
+1-212-546-4631, blaine.davis@bms.com, all of Bristol-Myers
Squibb Company
|
